Advertisement

Topics

Companies Related to "Cancer Research AstraZeneca launch functional genomics centre" [Most Relevant Company Matches] RSS

19:45 EDT 19th March 2019 | BioPortfolio

Here are the most relevant search results for "Cancer Research AstraZeneca launch functional genomics centre" found in our extensive corporate database of over 50,000 company records.

Showing "Cancer Research AstraZeneca launch functional genomics centre" Companies 1–25 of 8,900+

Extremely Relevant

Biotechnology Centre of Oslo (BiO)

The Biotechnology Centre of Oslo (BiO) is a centre for molecular biology, biotechnology and bioinformatics within the University of Oslo. The centre is devoted to research and post-graduate training.The Norwegian government has introduced a major national funding program for functional genomics (FUGE) and the University has designated molecular biology, biotechnology and bioinformatics priority ar...


Relevant

Oryzon Genomics

Oryzon genomics is a functional genomics company based in Barcelona, Spain. It was launched in 2001 as a spin-off of the Spanish National Research Council (CSIC) and the University of Barcelona, and has an international staff of 30 highly qualified scientists.

Clinical Research Centre

Centrum Badan Klinicznych Sp. z o.o. (Clinical Research Centre Ltd) is an independent, privately owned research centre conducting clinical research phase I-III, bioavailability and bioequivalence. We can act as a Leader Coordination Centre for clinical studies.CBK was established in March 2003 as a sister company of the Medical Centre Osteomed, in which clinical research has been conducted since 1...


Malaysian Genomics Resource Centre (MGRC)

MGRC provides an online bioinformatics service for ultra-high-throughput analysis of biological data (My Genomics Resource Centre). Annual subscription packages have been designed for a range of end-users, serving individual researchers and large corporations with high-throughput applications and new database platforms without the associated resource implications that come with managing and mainta...

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZe...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has been growing rapidly and now hosts over 100 researchers in the fields of functional, clinical and structural genomics, as well as genomics technologies and bioinformatics. Generally stated, the CGB is c...

DECODON GmbH

DECODON GmbH is a bioinformatics company that develops innovative software for the modern Life Sciences. Its bioinformatics tools are helping scientists to generate knowledge from the massive amounts of data that are accumulated by recent methods in global functional genomics.The company brings together specialists with diverse backgrounds from Molecular Biology, Computer Science and Mathematics. ...

NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer.The successful completion of the Human Genome Project signals a new age in medical discovery centered on protein research. The rapidly growing knowledge base of the human genome provides an unprecedented opportunity to launch a revolutionary paradigm ...

National Cancer Centre

Welcome to the website for National Cancer Centre, Singapore (NCC). As a national and regional centre of excellence, we are committed to excellence in research, education and clinical services.At NCC, we adopt a multidisciplinary and holistic approach to cancer treatment. We undertake training and education of medical, radiation and surgical oncologists and other allied health personnel to develop...

BioBam

BioBam, founded in 2011 and located in Valencia, Spain provides bioinformatics solutions for the functional annotation and analysis of genomic datasets to the scientific community. BioBam’s leading product, Blast2GO, counts with over 3000 scientific citations and is used by top private and public research institutions worldwide. It presents an all-in-...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billi...

Alpha Gene Incorporated

AlphaGene is a privately held - functional genomics company offering products and services to biotech and pharmaceutical companies engaged in drug discovery and development. AlphaGene uses its large inventory of full-length, novel cDNAs and bioinformatics expertise to bridge the gap between genomics and functional proteomics. The company focuses on differential gene expression to identify potentia...

Clinical Genomics Pty Ltd

Clinical Genomics is dedicated to improving patient outcomes through early detection of colorectal cancer. Clinical Genomics products span the full spectrum of colorectal cancer testing, lnSure® ONE™, a one sample fecal immunochemical test (FIT) for healthy adults to detect lower GI bleeding, and COLVERA®, a proprietary liquid biopsy blood test ...

Advanced Centre for Biochemical Engineering

The Advanced Centre has been a Research Council Centre since 1987, a national Interdisciplinary Research Centre since 1991 and is now operated as a Biotechnology and Biological Sciences Research Council (BBSRC) sponsored institute. In the last decade the Centre has received the largest research grant support in the field from the UK research councils. The Advanced Centre focuses on research which ...

Integrated Genomics Incorporated

Genome analysis: contract DNA sequencing and bioinformatics analysis of genome and EST projects. Includes functional annotation for ORFs and metabolic recostruction of entire genomes. The biopinformatics software package WIT Pro with a database of 250 annotated genomes (public and sequenced in house). Metabolic modeling for industrial applications such as targets for new anitibiotics and strain im...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines ar...

AstraZeneca HealthCare Foundation

Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote public awareness of healthcare issues, to promote public education of medical knowledge and to support or contribute to charitable and qualified exempt organizations consistent wit...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clinicians, business/research leaders and officials, from academia, research institutes, industry, healthcare and government organizations to realize the true potential of genomic med...

AstraZeneca AS

AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekke nyskapende og effektive legemidler. AstraZeneca har som forretningside å utvikle og markedsføre kostnadseffektive behandlingsløsninger basert på innovative legemidler for å fremme helse og livs...

AstraZeneca and Bristol-Myers Squibb

Dedicated to addressing the global burden of diabetes by advancing individualized patient care, AstraZeneca and Bristol-Myers Squibb are working in collaboration to research, develop and commercialize a versatile portfolio of innovative treatment options for diabetes and related metabolic disorders that aim to provide treatment effects beyond glucose contr...

Functional Formularies

Functional Formularies was founded in 2012 followed by the launch of Liquid Hope, the first organic, whole food enteral nutrition formula and oral meal replacement. Following the Food as Medicine model, Functional Formularies provides high quality, real food meal options to the tube-fed community, without any of the added sugars and fruit-based sweeteners ...

Ironwood Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals Co., Ltd.

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its i...

Bristol-Myers Squibb Company & AstraZeneca

Bristol-Myers Squibb and AstraZeneca entered into a collaboration in January 2007 to enable the companies to research, develop and commercialize select investigational drugs for type 2 diabetes. The Bristol-Myers Squibb/AstraZeneca Diabetes collaboration is dedicated to global patient care, improving patient outcomes and creating a new vision for the treat...

Bristol-Myers Squibb Company and AstraZeneca

Bristol-Myers Squibb and AstraZeneca entered into a collaboration in January 2007 to enable the companies to research, develop and commercialize select investigational drugs for type 2 diabetes. The Bristol-Myers Squibb/AstraZeneca Diabetes collaboration is dedicated to global patient care, improving patient outcomes and creating a new vision for the treat...

Bristol-Myers Squibb and AstraZeneca

Bristol-Myers Squibb and AstraZeneca entered into a collaboration in January 2007 to enable the companies to research, develop and commercialize select investigational drugs for type 2 diabetes. The Bristol-Myers Squibb/AstraZeneca Diabetes collaboration is dedicated to global patient care, improving patient outcomes and creating a new vision for the treat...


More From BioPortfolio on "Cancer Research AstraZeneca launch functional genomics centre"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks